Article
Interplay of machine learning and bioinformatics approaches to identify genetic biomarkers that affect survival of patients with glioblastoma
2024-01-01
Abstract excerpt
Glioblastoma, also known as grade IV astrocytoma, is an aggressive and quickly developing brain tumor whose median survival period is believed to be between 12 to 18 months. Patients with glioblastoma are at high risk of developing comorbidities like leukemia, atherosclerosis, autism, sudden cardiac death, and pancreatic neoplasms. Identification of influential biomarker genes is crucial to diagnose and design the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- da2d0d06-7482-5260-b5bb-587d45b1739a
- DOI
- 10.1016/j.imu.2024.101505
